BioVie Announces Efficacy Data from Phase 3 Trial of
Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker...
Source: globenewswire.com
Protocol Deviations News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Protocol Deviations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Protocol Deviations Today - Breaking & Trending Today
BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer's Disease
Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker…
Source: biztoc.com
Are We Doing Enough to Save Lives in Oncology Clinical Trials?
The landscape of clinical trials in oncology is rapidly evolving, driven by increasing research efforts and advancements in the field of clinical research.
Source: pharmacytimes.com
Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial | Critical Care Medicine | JAMA
This randomized clinical trial assesses the effect of selective decontamination of the digestive tract compared with standard care on in-hospital mortality amon
Source: jamanetwork.com
Phesi launches AI-driven Trial Accelerator™ to enable simulated trials and deliver comprehensive view of the patient throughout clinical development and commercialization
Phesi, a global provider of patient-centric data analytics, has today launched its AI-driven Trial Accelerator™ platform to facilitate real-time scenario modelling across patient, endpoint, country, KOL and investigator site allocation. Underpinned by the world's largest, most dynamic clinical trial database, the ...
Source: pharmiweb.com